Back

VA-ECMO-related complications seem not causally related to mortality in patients with acute myocardial infarction complicated by cardiogenic shock

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Acute heart failure and cardiogenic shock in acute coronary syndromes Shock ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Tharusan Thevathasan

Charite University Hospital, Berlin (Germany)

6 More presentations in this session

Presentation thumbnail
STEMI SHOCK outcomes with SCAI classification
Professor J. French (Sydney, AU)
Abstract Slides Video
Presentation thumbnail
Association of culprit lesions with in-hospital mortality in patients with acute coronary syndrome complicated by cardiogenic Shock
Doctor S. Matsushita (Kurashiki, JP)
Abstract Slides Video
Presentation thumbnail
Do DAN-GER-SHOCK eligible patients benefit from VA-ECMO treatment in infarct-related cardiogenic shock ? Results of an individual patient data meta-analysis.
Professor U. Zeymer (Ludwigshafen, DE)
Abstract Slides Video
Presentation thumbnail
Impact of inhaled nitric oxide therapy in patients with cardiogenic shock treated with veno-arterial extracorporeal membrane oxygenation combined with Impella
Doctor N. Yamada (Osaka, JP) Doctor M. Ueno (Osaka, JP)
Abstract Slides Video
Presentation thumbnail
Impact of late reperfusion therapy in patients with inferior ST-segment elevation myocardial infarction and right ventricular dysfunction: one size never fits all
Doctor A. Hernandez-Pineda (Barcelona, ES)
Abstract Slides Video

Access the full session

Session thumbnail
Acute heart failure and cardiogenic shock in acute coronary syndromes

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
ECMO-related complications and mortality in patients with infarct-related cardiogenic shock
thumbnail
Congress Presentation
Utility of venoarterial extracorporeal membrane oxygenation in patients with acute myocardial infarction complicated by cardiogenic shock
thumbnail
Congress Presentation
Do DAN-GER-SHOCK eligible patients benefit from VA-ECMO treatment in infarct-related cardiogenic shock ? Results of an individual patient data meta-analysis.

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources